GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Azure Health Technology Ltd (OTCPK:MOKOY) » Definitions » Net Cash per Share

Azure Health Technology (Azure Health Technology) Net Cash per Share : $-0.02 (As of Dec. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Azure Health Technology Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Azure Health Technology's Net Cash per Share for the quarter that ended in Dec. 2019 was $-0.02.

The historical rank and industry rank for Azure Health Technology's Net Cash per Share or its related term are showing as below:

MOKOY's Price-to-Net-Cash is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.28
* Ranked among companies with meaningful Price-to-Net-Cash only.

Azure Health Technology Net Cash per Share Historical Data

The historical data trend for Azure Health Technology's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azure Health Technology Net Cash per Share Chart

Azure Health Technology Annual Data
Trend Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun19
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.18 0.02 -0.06 -0.01

Azure Health Technology Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec18 Jun19 Dec19
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.06 - -0.01 -0.02

Competitive Comparison of Azure Health Technology's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Azure Health Technology's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azure Health Technology's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Azure Health Technology's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Azure Health Technology's Price-to-Net-Cash falls into.



Azure Health Technology Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Azure Health Technology's Net Cash per Share for the fiscal year that ended in Jun. 2019 is calculated as

Net Cash per Share (A: Jun. 2019 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.001-0.258-0)/41.4949
=-0.01

Azure Health Technology's Net Cash per Share for the quarter that ended in Dec. 2019 is calculated as

Net Cash per Share (Q: Dec. 2019 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0-0.773-0)/41.4949
=-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Azure Health Technology  (OTCPK:MOKOY) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Azure Health Technology Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Azure Health Technology's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Azure Health Technology (Azure Health Technology) Business Description

Traded in Other Exchanges
N/A
Address
Level 45, 19-29 Martin Place, Suite 03, Sydney, NSW, AUS, 2003
Azure Health Technology Ltd is engaged in research, development, distribution and marketing a range of health and therapeutic products and technologies, including innovative drugs, wellbeing supplements and medical devices.

Azure Health Technology (Azure Health Technology) Headlines

No Headlines